Literature DB >> 15618059

The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) in a cohort of 509 families with premature coronary artery disease.

Khaled Alfakih1, Richard A Lawrance, Azhar Maqbool, Kevin Walters, Stephen G Ball, Anthony J Balmforth, Alistair S Hall.   

Abstract

AIMS: To assess, in families with premature coronary artery disease (CAD), the possible association, with linkage, of the X-linked AT2 receptor (-1332 G/A) gene polymorphism and premature CAD. METHODS AND
RESULTS: We investigated 509 families with a history of premature CAD that consisted of one sibling affected with premature CAD and two unaffected siblings. Genotyping of subjects was performed using a restriction enzyme digestion of an initial 310 bp polymerase chain reaction fragment that included the AT2 (-1332 G/A) locus. The mean age of the 611 individuals affected by premature CAD at the time of event was 49.5 +/- 8.1 years. Conditional logistic regression analysis confirmed a significant predictive value of premature CAD for the covariates of hypertension, diabetes, dyslipidaemia, history of smoking, and male gender. The genetic data were analysed for these families using the X-linked sibling transmission/deletion test (XS-TDT) statistics program. In hemizygous men we observed evidence for association in the presence of linkage, for the AT2 (-1332 G/A) locus and premature CAD (P-exact value = 0.024) and also a trend towards association, in the presence of linkage, for this polymorphism and hypertension (P-exact value = 0.08).
CONCLUSIONS: We have observed evidence of association between the presence of linkage for the X-linked AT2 (-1332 G/A) polymorphism and premature CAD in hemizygous males.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15618059     DOI: 10.1093/eurheartj/ehi013

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

1.  Association of angiotensin II type I and type II receptor genes polymorphisms with the presence of premature coronary disease and metabolic syndrome.

Authors:  Tarek A Abd El-Aziz; Randa H Mohamed; Noha A Rezk
Journal:  Mol Biol Rep       Date:  2014-01-03       Impact factor: 2.316

Review 2.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

3.  AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy.

Authors:  Mahmoudreza Moradi; Zohreh Rahimi; Sonia Amiri; Ziba Rahimi; Mahmood Vessal; Hamid Nasri
Journal:  J Nephropathol       Date:  2015-07-01

4.  The association of APOC4 polymorphisms with premature coronary artery disease in a Chinese Han population.

Authors:  Shun Xu; Jie Cheng; Nan-hong Li; Yu-ning Chen; Meng-yun Cai; Sai-sai Tang; Haijiao Huang; Bing Zhang; Jin-ming Cen; Xi-li Yang; Can Chen; Xinguang Liu; Xing-dong Xiong
Journal:  Lipids Health Dis       Date:  2015-06-28       Impact factor: 3.876

5.  AT2R -1332 G:A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients.

Authors:  Zohreh Rahimi; Omid Mansouri Zaveleh; Ziba Rahimi; Ardeshir Abbasi
Journal:  J Renal Inj Prev       Date:  2013-09-01

Review 6.  AT2 receptors: functional relevance in cardiovascular disease.

Authors:  Emma S Jones; Antony Vinh; Claudia A McCarthy; Tracey A Gaspari; Robert E Widdop
Journal:  Pharmacol Ther       Date:  2008-08-31       Impact factor: 12.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.